Article info

Download PDFPDF

First participant diagnosed with Creutzfeldt-Jakob disease in the population-based Rotterdam Study was classified with mild cognitive impairment

Authors

  • Hata Karamujić-Čomić Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The NetherlandsNational Prion Disease Registry, Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Annemieke J M Rozemuller Department of Pathology, Amsterdam Neuroscience, Amsterdam UMC, VU University Medical Center, Amsterdam, The NetherlandsDepartment of Pathology, UMC Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • M Arfan Ikram Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The NetherlandsNational Prion Disease Registry, Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Cornelia M van Duijn Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The NetherlandsClinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Hata Karamujić-Čomić; h.comic{at}erasmusmc.nl
View Full Text

Citation

Karamujić-Čomić H, Rozemuller AJM, Ikram MA, et al
First participant diagnosed with Creutzfeldt-Jakob disease in the population-based Rotterdam Study was classified with mild cognitive impairment

Publication history

  • Accepted January 27, 2021
  • First published March 29, 2021.
Online issue publication 
March 29, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.